Dicyclomine HCl Injection, USP Now Available from Nexus

Nexus Pharmaceuticals has received U.S. Food and Drug Administration (FDA) approval for Dicyclomine Hydrochloride (HCl) Injection, USP in 20mg/2mL vial, the generic equivalent to Bentyl. Dicyclomine HCl, USP, is currently listed on the American Society of Health-System Pharmacists' drug shortage list.

"The addition of Dicyclomine Injection to our portfolio of products is another example of our commitment to provide medicines in shortage situations in convenient presentations," said Omair Ahmed, Chief Commercial Officer, Nexus Pharmaceuticals.

Dicyclomine HCL Injection is immediately available in cartons of five single dose vials, each containing 20mg of Dicyclomine. It is Latex and Preservative free.

Dicyclomine Hydrochloride Injection, USP is an antispasmodic and anticholinergic (antimuscarinic) agent indicated for the treatment of functional bowel/irritable bowel syndrome.

Register as Visitor to CPhI China 2019!

-----------------------------------------------------------------------
Editor's Note:

To apply for becoming a contributor of En-CPhI.cn,

welcome to send your CV and sample works to us,

Email: Julia.Zhang@ubmsinoexpo.com.